Odogwu, L., Mathieu, L., Blumenthal, G., Larkins, E., Goldberg, K. B., Griffin, N., . . . Pazdur, R. (2018). FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations. Oncologist.
Citación estilo ChicagoOdogwu, Lauretta, et al. "FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations." Oncologist 2018.
Cita MLAOdogwu, Lauretta, et al. "FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations." Oncologist 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.